MHC class I chain-related gene a (MICA) polymorphism and the different histological types of cervical cancer

Neoplasma

Volumn 52, Issue 5, 2005, Pages 369-373

  Chen, J R ^a   Lee, Y J ^a,b   Chen, T ^a   Wang, K L ^a   Dang, C W ^a   Chang, S C ^a   Liu, H F ^a   Yang, Y C ^a,b,c  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NURSING AND MANAGEMENT COLLEGE   (Taiwan)

Author keywords

Cervical cancer; MICA gene; Polymorphism

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; ARTICLE; CANCER INCIDENCE; CONTROLLED STUDY; DNA EXTRACTION; DNA POLYMORPHISM; EPITHELIUM CELL; FEMALE; GENE; GENE EXPRESSION; HUMAN; KERATINOCYTE; LEUKOCYTE; MAJOR CLINICAL STUDY; MICA GENE; POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; SWEDEN; T LYMPHOCYTE; TAIWAN; UNDIFFERENTIATED CARCINOMA; UTERINE CERVIX CANCER;

EID: 26044464559     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. APPLE RJ, ERLICH HA, KLITZ W, MANOS MM, BECKER TM, WHEELER CM. HLA-DR-DQ associations with cervical cancer show paillomavirus-type specificity. Nat Genet 1994; 6: 157.
2. BAHRAM S, BRESNAHAN N, GERAGHTY DE, SPIES T. A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci USA 1994; 91: 6259-6263.
3. BORUTA DM, SCHORGE JO, DUSKALA, CRUM CP, CASTRILLON DH, SHEETS EE. Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix. Gynecol Oncol 2001; 81: 82-87.
4. BUFFON GJ, DARLINGTON GJ. Isolation of DNA from biological specimens without extraction with phenol. Clin Chem 1985; 31: 164-165.
5. CHRISTMAS SE, BREW R, DENIZ J, TAYLOR JJ. T cell receptor heterogeneity of gamma delta T cell clones from human female reproductive tissues. Immunology 1993; 78:436-442.
6. DAS H, GROH V, KUIJL C. MICA engagement by human Vgamma2 Vdelta2 T cells enhances their antigen-dependent effector function. Immunity 2001; 15: 83-93.
7. FU YS, REAGAN JW. Pathology of the uterine cervix, vagina and vulva. Philadelphia: W.B. Saunders Co., 1989: 228-335.
8. GHADERI M, HJELMSTROM P, HALLMANS G, WIKLUND F, LENNER P et al. MICA gene polymorphism and the risk to develop cervical intraepithelial neoplasia. Hum Immunol 1999; 60: 970-973.
9. GHADERI M, NIKITINA ZAKE L, WALLIN K, WIKLUND F et al. Tumor necrosis factor A and MHC class I chain related gene A (MIC-A) polymorphisms in Swedish patients with cervical cancer. Hum Immunol 2001; 62: 1153-1158.
10. GLEW SS, DUGGAN KM, CABRERA T, STERN PL. HLA class II antigen expression in human papillomavirus-associated cervical cancer. Cancer Res 1992; 52: 4009.
11. GROH V, BAHRAM S, BAUER S, HERMAN A, BEAUCHAMP M, SPIES T. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastro-intestinal epithelium. Proc Natl Acad Sci USA 1996; 93: 12445-12450.
12. GROH V, RHINEHART R, RANDOLPH-HABECKER J, TOPP MS, RIDDELL SR, SPIES T. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol 2001; 2: 255-260.
13. GROH V, STEINLE A, BAUER S, SPIES T. Recognition of stress-induced MHC molecules by intestinal epithelial gamma delta T-cells. Science 1998; 279: 1737-1740.
14. GROH V, WU H, YEE C, SPIES T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 2002; 419: 734-738.
15. HOUCK JR, ROMANO PJ, BARTHOLOMEW M, SMITH PJ, KLOSZEWSKI F, VESELL ES. Do histocompatibility antigens influence the risk of head and neck carcinoma? Cancer 1992; 69: 2327-2332.
16. KOLDOVSKY P, HAAS I, BEIR H, GANZER U. Immimohistochemical examination of 11 cell lines derived from human head and neck squamous cell carcinomas, their recurrence or metastases. Europ Archi Oto-Rhino-Laryngo 1995; 252: 359-365.
17. LEA JS, COLEMAN RL, GARNER EO, DUSKA LR, MILLER DS, SCHORGE JO. Adenosquamous histology predicts poor outcome in low-risk stage IBI cervical adenocarcinoma. Gynecol Oncol 2003; 91: 558-562.
18. [ 18] LEE HH, CHAO HT, NG HT, CHOO KB. Direct molecular diagnosis of CYP21 mutations in congenital adrenal hyperplasia. J Med Genet 1996; 33: 371-375.
19. LEE YJ, HUANG FY, WANG CH, LO FS, TSAN KW et al. Polymorphism in the transmembrane region of the MICA gene and type 1 diabetes. J Pediatr Endocrinol Metab 2000; 13: 489-496.
20. LIU CJ, LEE YJ, LIU HF, DANG CW, CHANG CS et al. The increase in the frequency of MICA gene A6 allele in oral squamous cell carcinoma. J Oral Pathol Med. 2002; 31: 323-328.
21. LO FS, LEE YJ, HUANG CY, LIN CH, DANG CW, LIU HF. Polymorphism in the transmembrane region of the major histocompatibility class I chain-related gene: an association of five GCT repetitions with Graves' disease in children. Thyroid 2003; 13: 839-842.
22. MIZUKIN, OTAM, KIMURA M, OHNO S, ANDO H et al. Triplet repeat polymorphism in the transmembrane region of the MICA gene: A strong association of six GCT repetitions with Bechet disease. Proc Natl Acad Sci USA 1997; 94: 1298-1303.
23. OTA M, KATSUYAMA Y, MIZUKI N, ANDO H, FURIHATA K et al. Trinucleotide repeat polymorphism within exon 5 of the MICA gene (MHC class I chain-related Gene A): Allele frequency data in the nine population group Japanese, Northern Han, Hui, Uygur, Kazakhstan, Iranian, Saudi Arabian, Greek and Italian. Tissue Antigens 1997; 49: 448-454.
24. PARK Y, LEE H, SANJEEVI CB, EISENBARTH GS. MICA polymorphism is associated with type 1 diabetes in the Korean population. Diabetes Care 2001; 24: 33-38.
25. PETERSDORF EW, SHULER KB, LONGTON GM, SPIES T, HANSEN JA. Population study of allelic diversity in the human MHC class I-related MICA gene. Immunogenetics 1999; 49: 605-612.
26. SANJEEVI CB, HJELMSTROM P, HALLMANS G, WIKLUND F, LENNER P et al. Different HLA-DR-DQ halotypes are associated with cervical intraepithelial neoplasia among human papillomavirus type-16 seropositive and seronegative Sweden women. Int J Cancer 1996; 68: 409.
27. SCHIFFMAN M, HERRERO R, HILDESHEIM A, SCHERMAN ME, BRATTIM et al. HPV DNA testing in cervical cancer screening: result from women in a high risk province of Costra Rica. JAMA 2000; 283: 87.
28. SHIH SC, LEE YJ, LIU HF, DANG CW, CHAN SC et al. Polymorphism in transmembrane region of MICA gene and cholelithiasis. World J Gastroenterol 2003; 9: 1541-1544.
29. SLOOTWEG PJ, DE PAGTER M, DE WEGER RA, DE WILDE PC. Lymphocytes at tumor margins in patients with head and neck cancer. Int J Oral Maxillofac Surg 1994; 23: 286-289.
30. TIENG V, LE BOUGUENEC C, DU MERLE L. Binding of Eschirichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA. Proc Natl Acad Sci USA 2002; 99: 2977-2982.
31. WALLIN KL, WIKLUND F, ANGSTROM T, BERGMAN F, STENDAHL U et al. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 1999; 341(22): 1633-1638.
32. YANG YC, CHANG CL, CHEN ML. Effect of p53 polymorphism on the susceptibility of cervical cancer. Gynecol Obstet Invest 2001; 51: 197-201.
33. YANG YC, SHYONG WS, CHANG MS, CHEN YJ, LIN CH et al. Frequent gain of copy number on the long arm of chromosome 3 in human cervical adenocarcinoma. Cancer Genet Cytogenet 2001; 131: 48-53.
34. ZUR HAUSEN H. Papillomaviruses in human cancers. Proc Assoc AM Physicians 1999; 111(6): 581.